APSR2026-534

 
Regular
Submitted
Poster Presentation
 
AP14-053
P72
 
Format: PPTX Only
 
Format: PDF Only
08. Lung Cancer
1

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Hirsh Koyi * Gavle Hospital Department of Respiratory Medicine Gavle Sweden
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Presenting Author Details
Hirsh
Koyi
hirsh.koyi@regiongavleborg.se
+46703890101
61-70
Sweden
Case Report
Seven-Year Disease Control After SBRT for Primary Lung Cancer in a Transplanted Lung Ten Years After Lung Transplantation
Maximum 25 words
Abstract Content
 
 
 
 
<p>Lung transplantation is an established therapy for patients with end-stage emphysema and significantly improves survival and quality of life. As long-term outcomes after transplantation improve, late complications such as malignancy are increasingly recognized. Solid organ transplant recipients have an elevated risk of cancer, largely attributed to chronic immunosuppressive therapy. While lung cancer arising in the native lung has been reported, primary lung cancer developing within the transplanted lung is rare and poses unique diagnostic and therapeutic challenges.</p>
<p>We report the case of a patient with severe emphysema who underwent lung transplantation with excellent long-term graft function. Ten years after transplantation, routine follow-up imaging identified a 15-mm pulmonary lesion in the transplanted lung. Further diagnostic work-up confirmed a primary lung malignancy localized to the graft. Considering the patient’s prior lung transplantation, preserved graft function, and potential risks associated with surgical resection, stereotactic body radiotherapy (SBRT) was selected as the treatment modality. SBRT was well tolerated without significant toxicity or impairment of graft function. Follow-up imaging demonstrated an excellent treatment response with sustained local tumor control. After seven years of follow-up following SBRT, the patient remains clinically stable with no evidence of local recurrence or distant metastasis.</p>
<p>Primary lung cancer arising in a transplanted lung many years after transplantation is uncommon, and the optimal treatment approach remains uncertain. To our knowledge, reports describing the use of SBRT for lung cancer developing in a transplanted lung remain limited. The long-term disease control observed in this case highlights the potential role of SBRT in carefully selected transplant recipients.</p><p>SBRT may represent a safe and effective treatment option for localized lung cancer in lung transplant recipients. Long-term surveillance remains essential for early detection and management of malignancy in this patient population.</p>
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Lung transplantation; lung cancer; stereotactic body radiotherapy;
maximum 3 keywords and no abbreviations, separated by commas
 
286